Evidence map›Paper›PMID 35453305›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Polyphenolic HRMS Characterization, Contents and Antioxidant Activity of

María Isabel Quirós-Fallas, Felipe Vargas-Huertas, Silvia Quesada-Mora, Gabriela Azofeifa-Cordero, Krissia Wilhelm-Romero, Felipe Vásquez-Castro, Diego Alvarado-Corella, Andrés Sánchez-Kopper, Mirtha Navarro-Hoyos

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Identification of Antioxidant Metabolites from Five Plants (Antioxidants (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Metabolome Mining ofMetabolites · 2023
    Article
  10. Review
  11. Article
  12. QTOF-ESI MS Characterization and Antioxidant Activity ofMolecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

María Isabel Quirós-FallasBioactivity & Sustainable Development (BIODESS) Group, Department of Chemistry, University of Costa Rica (UCR), San Jose 2060, Costa Rica.ORCID 0000-0003-1377-6935
Felipe Vargas-HuertasBioactivity & Sustainable Development (BIODESS) Group, Department of Chemistry, University of Costa Rica (UCR), San Jose 2060, Costa Rica.ORCID 0000-0002-6270-0403
Silvia Quesada-MoraDepartment of Biochemistry, School of Medicine, University of Costa Rica (UCR), San Jose 2060, Costa Rica.ORCID 0000-0003-1926-5378
Gabriela Azofeifa-CorderoDepartment of Biochemistry, School of Medicine, University of Costa Rica (UCR), San Jose 2060, Costa Rica.ORCID 0000-0002-2484-9207
Krissia Wilhelm-RomeroBioactivity & Sustainable Development (BIODESS) Group, Department of Chemistry, University of Costa Rica (UCR), San Jose 2060, Costa Rica.ORCID 0000-0003-3763-1626
Felipe Vásquez-CastroBioactivity & Sustainable Development (BIODESS) Group, Department of Chemistry, University of Costa Rica (UCR), San Jose 2060, Costa Rica.
Diego Alvarado-CorellaBioactivity & Sustainable Development (BIODESS) Group, Department of Chemistry, University of Costa Rica (UCR), San Jose 2060, Costa Rica.
Andrés Sánchez-KopperCentro de Investigación y de Servicios Químicos y Microbiológicos (CEQIATEC), Department of Chemistry, Costa Rica Institute of Technology (TEC), Cartago 7050, Costa Rica.ORCID 0000-0002-8469-4366
Mirtha Navarro-HoyosBioactivity & Sustainable Development (BIODESS) Group, Department of Chemistry, University of Costa Rica (UCR), San Jose 2060, Costa Rica.ORCID 0000-0003-2115-4677
Universidad de Costa Rica · CRInstituto Tecnológico de Costa Rica · CR

Funding

University of Costa Rica 115-B8-150, 115-C0-001, 115-C1-501, ED-2033
6 · The paper itself

Abstract

Curcuma longa constitutes an important source of secondary metabolites that have been associated with multiple health benefits. For instance, curcumin, demethoxycurcumin and bisdemethoxycurcumin, have been found to perform important biological activities, such as anti-inflammatory, antioxidant, anticancer, antimicrobial, antihypertensive and anticoagulant. These promising results prompted this research to evaluate the polyphenols of C. longa rhizomes in Costa Rica. The present work reports a comprehensive study on the polyphenolic profile and the contents of the three main curcuminoids as well as the antioxidant activity of extracts from C. longa rhizomes (n = 12) produced in Costa Rica. Through UPLC-QTOF-ESI MS, a total of 33 polyphenols were identified, grouped in eight types of structures. In addition, our findings on the main curcuminoids using UPLC-DAD show all rhizomes complying with total curcuminoids (TC) content established by the United States Pharmacopeia (USP). At an individual level, samples NW-3 and NE-1 show the higher contents (118.7 and 125.0 mg/g dry material), representing more than twice the average values of the lowest samples. These samples also exhibit the highest Folin−Ciocalteu (FC) reducing capacity results as well as the best DPPH (IC50 15.21 and 16.07 µg extract/mL) and NO (IC50 between 52.5 and 54.3 µg extract/mL) antioxidant values. Further, Pearson correlation analysis findings indicated positive correlation (p < 0.05) between TC, CUR with FC results (r = 0.833 and r = 0.867 respectively) and negative correlation (p < 0.05) between CUR, TC and FC with DPPH results (r = −0.898, r = −0.911, and r = −0.890, respectively) and between NO results and DPPH (r = −0.805, p < 0.05). Finally, results for Principal Component Analysis (PCA) showed composition variability associated with their region of origin with products from the Northeastern (NE) region exhibiting higher average values for FC, TC and antioxidant activities. Further, PCA confirmed that two samples, namely NE-1 and NW-3, stand out by presenting the highest PC1 due to their particularly high TC, CUR and antioxidant activities. Consequently, our findings agree with previous results indicating the importance of C. longa extracts to elaborate products with potential benefits for health, while delivering extracts with higher levels of curcuminoids than previous reports and exhibiting high antioxidant activity.

Indexed as

bisdemethoxycurcuminCurcuma longacurcumindemethoxycurcuminmedicinal herbspolyphenolsQTOF-ESI MSUPLC

Identifiers

PMID35453305
PMCPMC9030737
OpenAlexW4220671758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.